American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

AHPA expresses concern about DEA using emergency scheduling authority to temporarily classify herb as schedule I substance

AHPA requests DEA to delay action

The American Herbal Products Association (AHPA) sent a letter to the U.S. Drug Enforcement Agency (DEA) urging the agency to reconsider using its emergency scheduling authority to temporarily place constituents of the herb kratom into schedule I of the Controlled Substances Act (CSA).

FDA Seeks Comment on Tentative Conclusion that Vinpocetine Is not a Dietary Ingredient

FDA maintains vinpocetine is a synthetic compound

A Food and Drug Administration (FDA) notice scheduled to be published tomorrow in the Federal Register requests comments on the agency's tentative conclusion that vinpocetine is not a dietary ingredient and is excluded from the definition of a dietary supplement.

Report from the 2016 Conference of Western Attorneys General Annual Meeting

By Douglas F. Gansler

In January, AHPA and UNPA launched a joint campaign to develop working relationships with state attorneys general (AG) and educate them about the herbal supplement industry to ensure they have an accurate understanding of the industry. Former Maryland Attorney General  and Past President of the National Association of Attorneys General. Gansler was hired to help deliver information and expertise about the industry to his colleagues.

Free AHPA Webinar Examines Revised NDI Draft Guidance

Herbal industry experts provide analysis of 2016 Draft Guidance for New Dietary Ingredients (NDIs)

Recorded August 30, 2016

FDA Releases Revised Draft of NDI Guidance

Revised draft replaces FDA’s 2011 draft

The Food and Drug Administration (FDA) today released revised draft guidance for new dietary ingredients (NDIs) to be published in the Federal Register on Friday. The revised draft replaces FDA’s 2011 draft.

Congress Clears Federal Mandatory GMO Labeling Bill to Be Signed into Law

Federal law would preempt state GMO labeling requirements

AHPA President Michael McGuffin comments on bill's passage

FDA Issues Final Rule Amending Food Facility Registration Regulations

Rule effective date: September 12, 2016

On July 13, 2016, FDA issued the final rule, “Amendments to Registration of Food Facilities.” The final rule implements the food facilities registration provisions of section 415 of the Food Drug and Cosmetic Act, as amended by the Food Safety Modernization Act (FSMA); amends and updates Food and Drug Administration (FDA) registration regulations; and improves the utility of the food registration database.

2016 AHPA Botanical Congress to Focus on Global Supply Chain, Financial Trends, Regulatory Issues

Breakout sessions will explore cannabis regulations and Aloe vera research

The American Herbal Products Association (AHPA) will hold its fifth annual Botanical Congress on Saturday, October 8 from 7:30am-5pm at SupplySide West in Las Vegas.

AHPA Opposes Blumenthal-Durbin Amendment to Restrict Some Supplement Sales on Military Bases

AHPA opposes separate regulatory standards that differ from existing general standards

“It is illogical as a regulatory principle and unworkable from a business perspective to require one set of rules for products sold through one channel of trade, such as stores on military bases, and another set of rules in the rest of the country,” said AHPA president, Michael McGuffin.

AHPA Urges FDA to Define "Natural" to Promote Clarity and Consistency

Consumers should not be misled by inconsistent or inaccurate uses of "natural"

The American Herbal Products Association (AHPA) submitted comments to the Food and Drug Administration (FDA) yesterday encouraging the agency to establish, through rulemaking, a regulatory definition for the term "natural" (and possibly other terms, such as "100% natural" and "made with natural [named ingredient(s)]") for the labeling of human food products, and other products regulated by FDA such as animal foods, cosmetics, and botanical drugs.
RSS
1234

2016 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.